Indacaterol The First Once-Daily Long-Acting Beta2 Agonist for COPD |
|
| Editor:
| Trifilieff, Alexandre |
| Series title: | Milestones in Drug Therapy Ser. |
| ISBN: | 978-3-0348-0708-1 |
| Publication Date: | Nov 2013 |
| Publisher: | Springer Basel AG
|
| Imprint: | Springer |
| Book Format: | Hardback |
| List Price: | USD $109.99 |
Book Description:
|
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled β2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled β2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.